Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0002022524-25-000003
Filing Date
2025-07-01
Accepted
2025-07-01 14:50:04
Documents
1
Effectiveness Date
2025-07-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 4978
  Complete submission text file 0002022524-25-000003.txt   6049
Mailing Address 2450 HOLCOMBE BLVD. SUITE 1200 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD. SUITE 1200 HOUSTON TX 77021 215-400-0133
ReEngage Therapeutics, Inc. (Filer) CIK: 0002022524 (see all company filings)

EIN.: 992186918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-549288 | Film No.: 251095792